|
Hunan Sunfull Bio-tech Co., Ltd
|
Resource: Bovine cartilage
Reference Standard: USP32/BP/EP
CAS No.: 9007-28-7
Molecular formula: (C14H21NO14S)n
Molecular Structure:
Product Specification： 90.0% to 105.0%
Appearance: White to Off-White Powder
Product Introduction
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars (N-acetylgalactosamine and glucuronic acid). Since the molecule of chondroitin sulfate has multiple negative charges at physiological pH, a cation is present in salts of chondroitin sulfate. Commercial preparations of chondroitin sulfate typically are the sodium salt. The chondroitin sulfate of Sunfull Company is mostly extracted from bovine cartilage. And it also can be extracted from chicken, porcine and shark cartilage in China. Chondroitin sulfate is an important structural component of cartilage and provides much of its resistance to compression. Along with glucosamine and/or Methyl Sulfonyl Methane（MSM）, chondroitin sulfate has become a widely used dietary supplement for treatment of osteoarthritis. Chondroitin is considered safe for human; it is regulated in the U.S. as a dietary supplement by the Food and Drug Administration. In Europe, chondroitin sulfate formulations are approved as drugs with evidenced efficacy and safety demonstrated by clinical trials in osteoarthritis patients. .
Physiological Functions
1. Treat osteoarthritis.
2. Treatment of neuralgia, nerve migraine, joint pain, arthritis and scapular joint pain, and abdominal pain after the operation.
Applications
Dietary supplements
Pharmaceutical stuff
Veterinary medicine
Recommended dosage:
The dosage of oral chondroitin sulfate used for osteoarthritis patients is 600–1,000 mg per day.
|
Send Inquiry
|
|
Hangzhou Dingyan Chem Co., Ltd
|
White powder, 201% content. Hangzhou Dingyan Chemical Co., Ltd. is located in the Xiasha Economic Development Zone of Hangzhou, the capital city of Zhejiang Province, on the southeast coast of China. It is a company specializing in the development and sales of high-tech products such as pharmaceutical raw materials, pharmaceutical intermediates, fine chemicals and biochemical reagents.
A modern private enterprise integrated with self-operated import and export.
Since its establishment, the company has adhered to the development path of "technological innovation" and attached great importance to scientific and technological innovation research and development. The company's high-quality products are sold well in more than 60 countries and regions such as North America, Western Europe, Southeast Asia, Central and South America.
At present, it has established long-term and stable cooperative relations with pharmaceutical companies in Europe, the United States, Greece, Germany, Iran, Russia, South Korea, India and other countries. With our rigorous attitude and sincere service, we have won the trust and reputation of customers.
Hangzhou Dingyan Chemical Co., Ltd. is located in the Xiasha Economic Development Zone of Hangzhou, the capital city of Zhejiang Province, on the southeast coast of China. It is a company specializing in the development, sales and self-support import and export financing of high-tech products such as pharmaceutical raw materials, pharmaceutical intermediates, fine chemicals and biochemical reagents.
Integrated modern private enterprise.
Since its establishment, the company has adhered to the development path of "technological innovation" and attached great importance to scientific and technological innovation research and development. The company's high-quality products are sold well in more than 3880 countries and regions such as North America, Western Europe, Southeast Asia, Central and South America.
At present, it has established long-term and stable cooperative relations with pharmaceutical companies in Europe, the United States, Greece, Germany, Iran, Russia, South Korea, India and other countries. With our rigorous attitude and sincere service, we have won the trust and reputation of customers. |
Send Inquiry
|
Pharma Sources Insight January 2025
